Gestational diabetes mellitus in a hospital in the city of Buenos Aires, Argentina

incidence, treatment, and frequency of screening for reclassification after childbirth

Authors

DOI:

https://doi.org/10.31053/1853.0605.v79.n3.36734

Keywords:

diabetes gestational, incidence, cohort studies

Abstract

Introduction: Gestational diabetes mellitus (GDM) is defined as glucose intolerance diagnosed during pregnancy. This pathology can be associated with maternal and feto-neonatal complications, both in the short and long term. The prevalence of GDM in Argentina (based on the diagnostic criteria of the Latin American Diabetes Association (ALAD), is estimated between 7.5-10% of pregnant women. Information in Argentina on the incidence of GDM is scarce. The objective of this work was to estimate the incidence of GDM, evaluate its treatment and the frequency of screening for postpartum reclassification of diabetes in a population of pregnant women treated at a private hospital in the city of Buenos Aires. Materials and methods: Retrospective cohort of pregnant women evaluated at the Hospital Italiano de Buenos Aires, Argentina between 2015 and 2018. Results: The cumulative incidence of GDM was 7.6% (95% CI 7.0-8, two). All patients received nutritional advice (food plan). Of the total number of pregnant women studied 229 (39.3%) required pharmacological treatment; Of these, 97 patients received insulin (16.7%) and 132 metformin (22.7%). Regarding the follow-up of the pathology, between six weeks and one year postpartum, 267 women (45.9%) underwent diabetes screening for reclassification. Screening frequency was higher in the insulin-treated group. Of the patients who underwent screening, 36 women (13.5%) had impaired fasting blood glucose, 16 women (6.0%) had impaired glucose tolerance, and 3 women (1.1%) were diagnosed with type 2 diabetes mellitus. two.Of these, 36 women (13.5%) had impaired fasting blood glucose, 16 women (6.0%) had impaired glucose tolerance, and 3 women (1.1%) were diagnosed with type 2 diabetes mellitus. Conclusion: GDM incidence was 7.6%. Less than half of the women diagnosed with GDM required pharmacological treatment. The frequency of diabetes screening up to one year postpartum for reclassification was similar to that reported.

Author Biographies

  • Vanina Pagotto, Hospital Italiano de Buenos Aires

    Médica especialista en Medicina Interna, Magister en diabetes, Magister en Investigación clínica. Médica investigadora del Departamento de Investigación del Hospital Italiano de Buenos Aires.

  • María Lourdes Posadas Martínez, Italian Hospital of Buenos Aires

    Physician specialist in Internal Medicine, Master in Clinical Research, Doctor of Medicine. Research Physician of the Research Department of the Italian Hospital of Buenos Aires

     

  • Susana Salzberg, Department of Clinical Research of the Centennial Institute of the City of Buenos Aires

    Medical specialist in nutrition and diabetes. Member of the diabetes and pregnancy and pharmacology committees of the Argentine Diabetes Society (SAD). Director of the Clinical Research Department of the Centennial Institute of the City of Buenos Aires.

  • Pablo Andres Pochettino, Italian Hospital of Buenos Aires

    Medical specialist in Obstetrics. Physician in charge of the Diabetes and Pregnancy Section of the Churruca Hospital in the City of Buenos Aires. Physician in charge of the Diabetes and Pregnancy Section of the Hospital Italiano de Buenos, Agustín Roca headquarters, province of Buenos Aires

References

S1. Salzberg S, Alvariñas J, López G, Gorbán de Lapertosa S, Linari MA, Falcón E, Juárez XE, Valinotti E, Marmol M, Rodriguez J, Gama M, Cerdas S, Báez S, Orozco R, Larrabure G, Rivas A, Cárdenas A, Camacho M, Barbero R, Vergara P, Seoane B, Hallens N, Lijerón L, Mercado N, Fierro A, Blanco P, Pérez LS, Barragan D, Rombalde E, Durand M, Barba AM. Guías de diagnóstico y tratamiento de diabetes gestacional. Rev ALAD 2016;6:155–69. Disponible en: https://www.revistaalad.com/abstract.php?id=343

Dos Santos PA, Madi JM, da Silva ER, Vergani DOP, de Araújo BF, Garcia RMR. Gestational Diabetes in the Population Served by Brazilian Public Health Care. Prevalence and Risk Factors. Rev Bras Ginecol Obstet. 2020 Jan;42(1):12-18. English. doi: 10.1055/s-0039-1700797.

Huidobro MA, Fulford A, Carrasco PE. Incidencia de diabetes gestacional y su relación con obesidad en embarazadas chilenas. Rev méd Chile. 2004;132(8):931–8. doi: 10.4067/S0034-98872004000800004

Huillca-Briceño A. La multiparidad como factor de riesgo de diabetes mellitus gestacional. Rev Cub Obstet Ginecol. 2016;42(2):189–98. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=68893

Ruiz-Hoyos BM, Londoño-Franco ÁL, Ramírez-Aristizábal RA. Prevalencia de Diabetes Mellitus Gestacional por curva de tolerancia a la glucosa en semanas 24 a 28. Cohorte prospectiva en Armenia Colombia, 2015-2016. Rev Colomb Obstet Ginecol. 2018 Jun 29;69(2):108–16. doi: 10.18597/rcog.3056

Shocron R, Bustos O, Nasif B. Prevalencia de Diabetes Gestacional en el Hospital Regional de Río Grande - Tierra del Fuego - Argentina. Colegio Profesional de ciencias bioquímicas de la Provincia de Córdoba [Internet]. 2015 Disponible en: http://www.cobico.com.ar/wp-content/archivos/2015/03/PREVALENCIA-DE-DIABETES-GESTACIONAL-FINAL-2.pdf

Gorban de Lapertosa S, Sucani S, Salzberg S, Alvariñas J, Faingold C, Jawerbaum A, Rovira G; DPSG-SAD Group. Prevalence of gestational diabetes mellitus in Argentina according to the Latin American Diabetes Association (ALAD) and International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria and the associated maternal-neonatal complications. Health Care Women Int. 2021;42(4-6):636-656. doi: 10.1080/07399332.2020.1800012.

Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005 Jun 16;352(24):2477-86. doi: 10.1056/NEJMoa042973.

Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008 May 8;358(19):2003-15. doi: 10.1056/NEJMoa0707193. Erratum in: N Engl J Med. 2008 Jul 3;359(1):106.

National Institute for Health and Care Excellence. Diabetes. In pregnancy: management from preconception to the postnatal period. [Internet]. NICE guidline 2015. Disponible en: https://www.nice.org.uk/guidance/ng3/resources/diabetes-in-pregnancy-management-from-preconception-to-the-postnatal-period-pdf-51038446021

Gandhi A, Malhotra N, Malhotra J, Gupta N, Malhotra Bora M. Principles of Critical Care in Obstetrics. Springer; 2016. 376 p.

Arizmendi J, Carmona Pertuz V, Colmenares A, Gómez Hoyos D, Palomo T. Diabetes gestacional y complicaciones neonatales. Revista Med. 2012;20(2):50–59. doi: 10.18359/rmed.1200

Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018 Oct 26;19(11):3342. doi: 10.3390/ijms19113342.

El Ouahabi H, Doubi S, Boujraf S, Ajdi F. Gestational Diabetes and Risk of Developing Postpartum Type 2 Diabetes: How to Improve Follow-up? Int J Prev Med. 2019 May 6;10:51. doi: 10.4103/ijpvm.IJPVM_3_17.

Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol. 2006 Dec;108(6):1456-62. doi: 10.1097/01.AOG.0000245446.85868.73.

Blatt AJ, Nakamoto JM, Kaufman HW. Gaps in diabetes screening during pregnancy and postpartum. Obstet Gynecol. 2011 Jan;117(1):61-68. doi: 10.1097/AOG.0b013e3181fe424b.

Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020 May 13;369:m1361. doi: 10.1136/bmj.m1361.

Schmid B, da Silva NN. Estimação de sub-registro de nascidos vivos pelo método de captura e recaptura, Sergipe. Revista de Saúde Pública. 2011;45(6):1088–98. doi: 10.1590/S0034-89102011000600011

Lawrence JM, Contreras R, Chen W, Sacks DA. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care. 2008 May;31(5):899-904. doi: 10.2337/dc07-2345.

Pagotto V, Martínez MLP, Giunta DH, Pochettino PA, Salzberg S. Evaluación de la tendencia de diabetes gestacional en un período de 11 años en Buenos Aires, Argentina. Rev Méd Chile. 2020; 148(8):1068–74. doi: 10.4067/s0034-98872020000801068.

Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS; Kaiser Permanente of Colorado GDM Screening Program. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care. 2005 Mar;28(3):579-84. doi: 10.2337/diacare.28.3.579.

Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991 Dec;165(6 Pt 1):1667-72. doi: 10.1016/0002-9378(91)90012-g.

Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health. 2010 Jun;100(6):1047-52. doi: 10.2105/AJPH.2009.172890.

Kautzky-Willer A, Harreiter J, Winhofer-Stöckl Y, Bancher-Todesca D, Berger A, Repa A, Lechleitner M, Weitgasser R. Gestationsdiabetes (GDM) (Update 2019) [Gestational diabetes mellitus (Update 2019)]. Wien Klin Wochenschr. 2019 May;131(Suppl 1):91-102. German. doi: 10.1007/s00508-018-1419-8.

Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007 Aug;30(8):2070-6. doi: 10.2337/dc06-2559a.

Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One. 2013 May 27;8(5):e64585. doi: 10.1371/journal.pone.0064585.

Li Z, Cheng Y, Wang D, Chen H, Chen H, Ming WK, Wang Z. Incidence Rate of Type 2 Diabetes Mellitus after Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of 170,139 Women. J Diabetes Res. 2020 Apr 27;2020:3076463. doi: 10.1155/2020/3076463.

Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A, Walker EA. Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care. 2007 Sep;30(9):2281-6. doi: 10.2337/dc07-0618.

Hjelm K, Bard K, Berntorp K, Apelqvist J. Beliefs about health and illness postpartum in women born in Sweden and the Middle East. Midwifery. 2009 Oct;25(5):564-75. doi: 10.1016/j.midw.2007.08.007.

Published

2022-09-16

Issue

Section

Original Papers

How to Cite

1.
Gestational diabetes mellitus in a hospital in the city of Buenos Aires, Argentina: incidence, treatment, and frequency of screening for reclassification after childbirth. Rev Fac Cien Med Univ Nac Cordoba [Internet]. 2022 Sep. 16 [cited 2024 Sep. 28];79(3):248-53. Available from: https://revistas.unc.edu.ar/index.php/med/article/view/36734

Similar Articles

1-10 of 614

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)